LEOPOLDO
PÉREZ DE ISLA
Profesor asociado de Ciencias de la Salud
Hospital Universitario Reina Sofia
Córdoba, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (22)
2024
-
Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients
Atherosclerosis, Vol. 392
-
Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97
2023
-
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Circulation, Vol. 147, Núm. 19, pp. 1436-1443
2022
-
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort
European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801
2021
-
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study
Atherosclerosis, Vol. 317, pp. 52-58
-
Lipoprotein(a), LDL-cholesterol, and hypertension: Predictors of the need for aortic valve replacement in familial hypercholesterolaemia
European Heart Journal, Vol. 42, Núm. 22, pp. 2201-2211
2020
-
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834
-
Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 2, pp. 161-167
2019
-
Lifestyle and cardiovascular risk factors in Spanish, Portuguese and Latin-American cardiologists. PREDICA survey
REC: CardioClinics, Vol. 54, Núm. 1, pp. 17-26
-
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
Journal of Clinical Lipidology, Vol. 13, Núm. 6, pp. 989-996
-
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Atherosclerosis, Vol. 285, pp. 17-22
-
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia
Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1029-1039
2018
-
Consensus Document of the SEMI, semFYC, SEN, and SEC on Focused Cardiac Ultrasound in Spain
Revista Espanola de Cardiologia, Vol. 71, Núm. 11, pp. 935-940
-
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study
Journal of Clinical Lipidology, Vol. 12, Núm. 4, pp. 948-957
-
Selection of the Best of 2017 in Cardiac Imaging and Structural Interventionism
Revista Espanola de Cardiologia, Vol. 71, Núm. 2, pp. 125-126
2017
-
Consecución de objetivos terapéuticos de colesterol LDL en niños y adolescentes con hipercolesterolemia familiar. Registro longitudinal SAFEHEART
Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 444-450
-
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia
Journal of Clinical Lipidology, Vol. 11, Núm. 1, pp. 260-271
-
Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)
Circulation, Vol. 135, Núm. 22, pp. 2133-2144
2016
-
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry
Journal of Clinical Lipidology, Vol. 10, Núm. 4, pp. 953-961
-
Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250